AVITA Medical

AVITA Medical (NASDAQ: RCEL, ASX: AVH) is a leader in therapeutic acute wound care, delivering solutions that optimize healing and accelerate patient recovery.

[AVITA Medical @AvitaMedical]

#News: AVITA Medical ($RCEL, $AVH) receives CE Mark for RECELL® GO, enabling commercialization across Europe. Press Release: https://t.co/2ctdM7zmwG..

[AVITA Medical @AvitaMedical]

Please join us today, Monday, September 8, at 4:05 p.m. EST, for a fireside chat with Jim Corbett, our chief executive officer, at the Morgan Stanley 23rd Annual Global Healthcare Conference. You can listen to the webcast live or later on demand at: https://t.co/0pNo63XNRu

[AVITA Medical @AvitaMedical]

36% shorter hospital stays.
Data presented at #EBA2025 reinforces that RECELL® leads to significantly reduced length of stay vs. traditional grafting.
Fewer days in hospital = lower costs, faster recovery, greater system efficiency.
https://t.co/P2LchKeeRI..
#MedTech #Healthcare

[AVITA Medical @AvitaMedical]

Our CEO Jim Corbett joined On the Couch to share our mission and what’s ahead for AVITA Medical.

Key themes:
✅Innovation in acute wound care
✅Growth drivers in the next 12 months
✅Why “36” is our rallying number

🎧 Hear the full conversation: https://t.co/I6rp8LSykh

[AVITA Medical @AvitaMedical]

"Not only was the healing time so much faster, but the way that I look today is because of RECELL."

Tiara Bowers suffered severe burns from an explosive house fire. Her doctor recommended RECELL® to expedite healing at the cellular level. Watch her story: https://t.co/ZywiIUTYCL

[AVITA Medical @AvitaMedical]

Rich Raymond, RN, presented a case study during the recent AVITA Medical Acute Wound Care Showcase. The study featured outcomes of a pediatric burn treated with PermeaDerm®.

Watch as he shares the story of his patient's healing journey. https://t.co/I9tkFmhXtH

[AVITA Medical @AvitaMedical]

Katie Bush, PhD, Senior Vice President of Scientific and Medical Affairs at AVITA Medical, shares how RECELL® is evolving and what its expanding role could mean for plastic and reconstructive surgery in a recent Plastic Surgery Practice interview.

https://t.co/7A9HFRKExw

[AVITA Medical @AvitaMedical]

Katie Bush, Senior Vice President of Scientific and Medical Affairs, was recently interviewed by Plastic Surgery Practice (PSP) about RECELL Spray-On Skin™ Cells for acute wound care.

Read it here: https://t.co/7DvBEq453f

[AVITA Medical @AvitaMedical]

#NEWS We’ve successfully completed an equity placement on the ASX, securing approximately US$15 million (~A$23 million) to support our continued growth. You can read our press release for the full details: https://t.co/JTlbuMG8oa $RCEL $AVH

[AVITA Medical @AvitaMedical]

View a case study in which PermeaDerm® was applied to a surgical wound prior to autografting. The surgical team opted for PermeaDerm over an allograft due to its cost-effectiveness, flexibility, and transparency.

https://t.co/bOfVK89Mg6

[AVITA Medical @AvitaMedical]

Healthcare professional education is one of our top priorities.

If your team would like to participate in a cadaver lab or hands-on learning workshop about our acute wound care solutions, reach out to your local sales representative.

[AVITA Medical @AvitaMedical]

PermeaDerm® biosynthetic wound matrix is a next-generation surgical dressing with multiple features that benefit clinicians, patients, and facilities. Clinicians adopt it into their standard of care for its ease of use, single application, and customizable moisture management.

[AVITA Medical @AvitaMedical]

In a recent clinical case series describing the first patient use, Cohealyx™ demonstrated wound bed readiness in as little as five to ten days.

Read more on this clinical case: https://t.co/NnvSWlZOnJ

[AVITA Medical @AvitaMedical]

A peer-reviewed, head-to-head pre-clinical study demonstrated favorable performance by Cohealyx™ collagen dermal matrix across key outcomes.

See how Cohealyx stands out: https://t.co/60ZB8fFEnr

[AVITA Medical @AvitaMedical]

When it's time to graft, it's time to consider RECELL® Spray-On Skin™ Cells.

RECELL technology accelerates healing at the cellular level and reduces donor skin requirements.

[AVITA Medical @AvitaMedical]

Join us from July 22-23, 2025 at IDGA’s VA Healthcare conference in Arlington, VA along with 500+ senior leaders, clinicians, nurses, administrators, and technology professionals from across the veterans' healthcare sector.

#VAhealthcare #Veterans

[AVITA Medical @AvitaMedical]

Sharon Grason, PhD, RN, writes about the importance of reducing wound healing time using a two-stage approach in her latest article on enhancing traumatic wound management.

Read the full article here: https://t.co/FK3kjhMb1u

[AVITA Medical @AvitaMedical]

International healthcare professionals are invited to attend a webinar with Anjay Khandelwal, MD, FACS, FICS, as he discusses RECELL Spray-On Skin™ Cells for pediatric and vulnerable populations.

Register: https://t.co/Jma4iUMs80

Content is approved for International use only.

[AVITA Medical @AvitaMedical]

The future of acute wound care is here!

View a clinical case of a 440cm2 full-thickness wound resulting from surgical excision. Cohealyx™ collagen dermal matrix was applied, followed by meshed autograft and RECELL® Spray-On Skin™ Cells.

https://t.co/TQGydyDSI7

[AVITA Medical @AvitaMedical]

AVITA Medical participated in the recent Plastic Surgery Congress in Sydney, Australia. Winthrop Professor Fiona Wood, FRCS, FRACS, AM, an inventor of RECELL Spray-On Skin™ Cells, delivered an educational lecture on the use of cell-based therapies in skin repair.